Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Tepnel Life Science

2 Sep 2005 11:36

Man Financial Limited02 September 2005 FORM 8.3 DEALINGS BY PERSONS WHO OWN OR CONTROL 1% OR MORE OF ANY CLASS OF RELEVANT SECURITY (Rule 8.3 of The City Code on Takeovers and Mergers) Name of purchaser/vendor * MAN FINANCIAL LIMITED Company dealt in Tepnel Life Sciences PLC Relevant security dealt in ORDINARY If a connected EFM, name of offeree/offeror N/Awith which connected If a connected EFM, nature of connection # N/A Date of dealing 01/09/05 DEALINGS + Amount bought Price per unit (GBP) 25,000 0.0775 Amount sold Price per unit (GBP) Resultant total amount and percentage of the 2,840,000 / 2.13%same relevant security owned or controlled IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? YES Date of disclosure 02/09/05 Contact name Stewart Horner Telephone number 020-7144-4201 * Specify the owner or controller in addition to the person dealing. The naming of nominees or vehicle companies isinsufficient. In the case of disclosure of dealings by fund managers on behalf of discretionary clients, the clientsneed not be named. # See the definition of "connected fund managers and principal traders" in the Definitions Section of the Code. + If disclosing dealings/holdings in derivatives or options, please attach Supplemental Form 8 (Derivative) orSupplemental Form 8 (Option), as appropriate. For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the TakeoverPanel's website at www.thetakeoverpanel.org.uk. SUPPLEMENTAL FORM 8 (DERIVATIVE) DEALINGS/HOLDINGS IN DERIVATIVES (This form should be attached to Form 8.1, Form 8.1(b)(ii), Form 8.2 or Form 8.3, as appropriate) Description of all derivative products disclosed on this A Contract for Difference or CFD is an agreement betweenform two parties to exchange, at the close of the contract, the difference between the opening price and the closing price, multiplied by the number of reference shares specified within the contract. The reference shares are the underlying shares specified in the CFD. The economic performance of the CFD is determined by the performance of the underlying reference shares. Although CFDs replicate the price movement of the underlying reference shares, they convey no right or requirement to acquire or deliver the physical shares. The contract value of a CFD is defined as the number of reference shares specified in the contract, multiplied by the price of the underlying reference share. If a client of Man takes a long position, the client will make a profit if the contract value increases. Conversely, if a client of Man takes a short position, the client will benefit if the contract value falls. The CFD contracts detailed below are open-ended and without predetermined expiry/close value. A Spread Bet is a product whereby the client to whom the product is sold can realise a gain or a loss depending on whether the price of the underlying share increases above or falls below the reference price. A client's Spread bet position is described as the client's stake. A stake is expressed in pounds (sterling) per point and a point is the price in pence of the underlying shares. A client with a stake of £100 per point will make a gain of £100 for every penny increase in the underlying shares and the client has an exposure equivalent to holding 10,000 shares. Full details of any agreement, arrangement or Noneunderstanding between the person disclosing and any otherperson relating to the voting rights or futureacquisition or disposal of any relevant securities towhich any derivative referred to on this form isreferenced. If none, this should be stated. WRITING/ENTERING INTO A DERIVATIVE Product name Transaction Writing/entering into Number of securities to Reference price Maturity date (indicate as which the derivative is (currency must dateeg long CFD applicable) referenced be stated) LONG CFD 01/09/05 Written 25,000 0.0775 NOT DATED CLOSING OUT A DERIVATIVE Product name Transaction Number of securities to which the Reference price (GBP) Closing out price date derivative is referenced (GBP)eg long CFD DETAILS OF OPEN DERIVATIVES (excluding any transaction set out above) Product name Transaction Written/entered into Number of securities to Reference price Maturity date (indicate as which the derivative is (currency must dateeg long CFD applicable) referenced be stated) GBP LONG CFD 30/08/05 Written 150,000 0.0763 Undated LONG CFD 10/08/05 Written 100,000 0.0900 Undated LONG CFD 25/07/05 Written 2,000,000 0.0888 Undated LONG CFD 15/07/05 Written 50,000 0.1025 Undated LONG CFD 20/05/04 Written 250,000 0.0825 Undated LONG CFD 06/02/04 Written 250,000 0.1350 Undated LONG CFD 08/08/03 Written 15,000 0.1950 Undated For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the TakeoverPanel's website at www.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 20228:47 amRNSForm 8.5 (EPT/RI)
6th Jun 20228:29 amRNSForm 8.3 - Ted Baker PLC
1st Jun 20221:58 pmRNSForm 8.3 - Ted Baker plc
1st Jun 20221:45 pmRNSTotal Voting Rights
1st Jun 20229:30 amRNSForm 8.5 (EPT/RI)
1st Jun 20228:34 amRNSForm 8.3 - TED BAKER PLC
31st May 20223:21 pmRNSForm 8.3 - Ted Baker Plc
31st May 202212:51 pmRNSForm 8.3 - Ted Baker plc
31st May 20229:29 amRNSForm 8.5 (EPT/RI)
31st May 20228:47 amRNSForm 8.3 - TED BAKER PLC
31st May 20228:15 amRNSForm 8.5 (EPT/RI)
30th May 20222:21 pmRNSForm 8.3 - Ted Baker plc
30th May 20222:08 pmRNSForm 8.3 - Ted Baker PLC
30th May 202211:43 amRNSForm 8.5 (EPT/RI)
30th May 20229:47 amRNSForm 8.3 - Ted Baker PLC
30th May 20228:54 amRNSForm 8.5 (EPT/RI)
27th May 20223:15 pmRNSForm 8.3 - Ted Baker plc
27th May 202212:41 pmRNSForm 8.3 - Ted Baker plc
27th May 20229:51 amRNSForm 8.3 - Ted Baker PLC
27th May 20228:59 amRNSForm 8.5 (EPT/RI)
27th May 20228:31 amRNSForm 8.5 (EPT/RI)
26th May 20222:36 pmRNSForm 8.3 - Ted Baker plc
26th May 202210:19 amRNSPreliminary Results and Q1 trading update
26th May 20229:42 amRNSForm 8.5 (EPT/RI)
26th May 20228:24 amRNSForm 8.3 - TED BAKER PLC
26th May 20227:58 amRNSTiming of Full Year Results
25th May 20223:10 pmRNSForm 8.3 -TED BAKER PLC
25th May 202211:01 amRNSForm 8.5 (EPT/RI)
25th May 20229:56 amRNSForm 8.5 (EPT/RI)
25th May 20229:24 amRNSForm 8.3 - Ted Baker PLC
24th May 20223:22 pmRNSForm 8.3 - Ted Baker Plc
24th May 20221:59 pmRNSForm 8.3 - Ted Baker plc
24th May 202210:21 amRNSForm 8.3 - Ted Baker PLC
24th May 20229:19 amRNSForm 8.5 (EPT/RI)
24th May 20228:25 amRNSForm 8.3 - TED BAKER PLC
23rd May 20223:55 pmRNSForm 8.3 - TED BAKER PLC
23rd May 20223:19 pmRNSForm 8.3 - Ted Baker plc
23rd May 20229:39 amRNSForm 8.3 - Ted Baker PLC
23rd May 20229:22 amRNSForm 8.5 (EPT/RI)
23rd May 20227:00 amRNSUpdate on Formal Sale Process
20th May 20222:01 pmRNSForm 8.3 - TED BAKER PLC
20th May 20229:41 amRNSForm 8.3 - Ted Baker PLC
20th May 20229:09 amRNSForm 8.5 (EPT/RI)
20th May 20228:48 amRNSForm 8.5 (EPT/RI)
19th May 20221:40 pmRNSForm 8.3 - Ted Baker plc
19th May 202212:05 pmRNSForm 8.5 (EPT/RI)
19th May 202211:30 amRNSForm 8.3 - Ted Baker PLC
19th May 20229:58 amBUSForm 8.3 - TED BAKER PLC
18th May 202211:55 amRNSForm 8.3 - Ted Baker plc
18th May 202210:11 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.